Recently, a MYCN signature was proposed in neuroblastoma based upon expression changes following knockdown of MYCN in the MYCN-amplified IMR32 cell line that also correlated with MYCN expression in neuroblastoma tumors [38]. Here, MYCN is linked to neuroblastoma.